Correlation Between Krystal Biotech and Rain Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Rain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Rain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krystal Biotech and Rain Therapeutics, you can compare the effects of market volatilities on Krystal Biotech and Rain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Rain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Rain Therapeutics.

Diversification Opportunities for Krystal Biotech and Rain Therapeutics

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Krystal and Rain is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Rain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rain Therapeutics and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Rain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rain Therapeutics has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Rain Therapeutics go up and down completely randomly.

Pair Corralation between Krystal Biotech and Rain Therapeutics

If you would invest  141.00  in Rain Therapeutics on August 15, 2024 and sell it today you would earn a total of  0.00  from holding Rain Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy2.38%
ValuesDaily Returns

Krystal Biotech  vs.  Rain Therapeutics

 Performance 
       Timeline  
Krystal Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Krystal Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Krystal Biotech is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Rain Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rain Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Rain Therapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Krystal Biotech and Rain Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krystal Biotech and Rain Therapeutics

The main advantage of trading using opposite Krystal Biotech and Rain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Rain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rain Therapeutics will offset losses from the drop in Rain Therapeutics' long position.
The idea behind Krystal Biotech and Rain Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope